Clinical Trial Update: Safety and Accuracy Study of Regadenoson Atropine Combination for Stress Echocardiography in Identification of Coronary Artery Disease

View source ↗

Summary

A study update evaluating the safety and accuracy of a regadenoson and atropine combination for stress echocardiography in detecting coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Atropine (atropine)
• Regadenoson (Lexiscan) (regadenoson)

Snippet

Sponsor: Henry Ford Health System | Conditions: Coronary Artery Disease | Status: UNKNOWN